Vestibular Prosthesis May Treat Balance Disorders
The market for treating vestibular disorders may be a potential area of growth for the neurotechnology industry. There is significant unmet medical need for inner ear disorders such as Meniere’s disease, which produces vertigo, tinnitus, and other symptoms. Although there is medication which can help once an attack is underway, there is currently no long-term therapy which can resolve the disease completely.
Terms and Terminology
It’s nearly impossible to edit a newsletter like Neurotech Business Report without making reference to the individuals who are the intended recipients of neurotech products and therapies. So it caught our attention when we received an email from a new organization called RespectAbilityUSA with advice on how to refer to people with disabilities. Some of the advice is just plain obvious—don’t use the word “retard” or “retarded kid” to refer to someone with a cognitive or learning disability.
Neurotech Branches Out
News that British pharmaceutical giant GlaxoSmithKline has started a venture fund to invest in “bioelectronic” technologies [see article, p1] represents a positive development for the neurotechnology industry. The new fund, and the efforts of GSK’s Bioelectronics R&D unit, not only raises the specter of a new source of funding and partnership for neurotech startups, it opens the door to an expansion of the role that neurotech devices have played in healthcare.
Involuntary Neurotech
Clinicians, researchers, and vendors in the neurotechnology field have a lot more to think about given recent news about involuntary outpatient commitment programs. One such program in New York State, known as Kendra’s Law in honor of a victim of a subway attack schizophrenia, provides intensive caseworker monitoring to ensure certain psychiatric patients obtain outpatient treatment. While most of…
A Win for Everyone
The mood was upbeat at the INS meeting in Berlin earlier this month with the news of St. Jude Medical’s investment in Spinal Modulation [see article, p4, Conference Report, p7]. In an industry beset by misfortunes, from failed clinical trials to lengthy approval cycles, to tighter capital availability, any kind of good news was welcome to investors, startups, and established players alike. With one…
Press Release
New Publishing Firm Devoted to Neurotechnology Market Neurotech Reports, a Torrance, CA based publisher of newsletters and market research reports, has been launched to provide strategic information on the new and growing field of neurotechnology. Neurotechnology is defined as the application of electronics and engineering to human nervous system function. It is a distinct field from biotechnology, which concerns itself largely with molecular and genetic engineering approaches to human biology.
Press Release
Neurotechnology Pioneers and Entrepreneurs to Highlight October Investment Conference Some of the world’s leading researchers and entrepreneurs in neural prostheses, neurostimulation, and advanced brain sensing will participate in the second annual Neurotech Leaders Forum, to be held in San Francisco October 3, 2002. The full-day event offers an opportunity for researchers and executives in the neurotechnology field to interact with venture capital firms and other funding organizations.
Press Release
Neural Prosthesis Recipient to Keynote 2003 Neurotech Leaders Forum Jennifer French, one of the first recipients of an experimental standing/transfer prosthesis that allows paraplegics to stand up using their own paralyzed leg muscles, will deliver the keynote talk at the 2003 Neurotech Leaders Forum in San Francisco. The event, a full-day management and investment conference directed at neurotechn…
Press Release
Neurotechnology Entrepreneur to Keynote 2005 Neurotech Leaders Forum Alan Levy, President and CEO of Northstar Neuroscience, Inc., will keynote the 2005 Neurotech Leaders Forum, to be held in San Francisco, CA October 20-21. Levy, founder of one of the most promising venture capital-backed neurotechnology firms, will address many of the issues involved with launching a neurotechnology startup. The fifth annual event, produced , will be held at the Crowne Plaza San Francisco International Airport.
Special Offer for Industry Leaders
Save over $500 With Our Special Offer for Industry Leaders! For a limited time, you can order your copy of The Market for Neurotechnology, 2001-2005, plus your charter subscription to Neurotech Business Report for the special price of $1395,a savings of $500 off the regular price for both products. When you do so, you will not only save money, you’ll gain exclusive access to the findings and the data before your competitors do.